• Overview
    mAbxience
    Our Vision,
    Mission, Culture
  • Business
    Growth Story
    Leadership
    Team
  • Biopharmaceutical
    Development
    • Pipeline
    • R&D
    • Quality Philosophy
  • Manufacturing
    & Supply
    • Commercial Supply
    • CDMO
    • mAbxience Sites
  • News
  • Market &
    industry news
  • Videos CSR
  • Location
  • Business Development
    & Licencies
  • Join
    us
  • About us
    • Overview
      mAbxience
    • Our Vision,
      Mission, Culture
    • Business
      Growth Story
    • Leadership
      Team
  • What we do?
    • Biopharmaceutical
      Development
      • Pipeline
      • R&D
      • Quality Philosophy
    • Manufacturing
      & Supply
      • Commercial Supply
      • CDMO
      • mAbxience Sites
  • Partnerships
  • Media center
    • News
    • Market &
      industry news
    • Videos
    • CSR
  • Contact us
    • Location
    • Business Development
      & Licencies
    • Join
      us

mAbxience | Glossary

Find here all you need!

VIEW ALL
A - Z
Z - A
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

T

TRACEABILITY

S

SUBSTITUTION

SINGLE-USE TECHNOLOGY

SIMILARITY

R

Risk management system

Q

QUALITY

P

PHARMACOVIGILANCE

PHARMACOKINETIC TEST

PHARMACODYNAMIC TEST

PERFORMACE QUALIFICATION

Patent

O

OUTSOURCING ACTIVITIES

ORIGINATOR COMPANY

M

MONOCLONAL ANTIBODY (MAB)

MEDIA

MCB (MASTER CELL BANK)

Marketing authorisation

MANUFACTURING SCALE PRODUCTION

Mab

I

INTERCHANGEABILITY

INNOVATIVE REFERENCE DRUG

IMMUNOGENICITY

H

HLA

HIGH-AFFINITY ANTIBODY

HAPTEN

G

GMP

GLYCOSYLATION

GENETIC ENGINEERING

GENE TRANSFER

F

Fucosylation

FORMULATION

FINGERPRINT-LIKE

FEED

FDA

E

EXTRAPOLATION

EMA

C

COMPARABILITY

CLONE

CLINICAL STUDY TRIAL

CHMP

CHIMERIC TRANSGENE

cGMP

CELL LINE

CELL HARVESTING

CELL CULTURE

CELL BANK

CBER

B

BIOTECHNOLOGY

BIOSIMILARITY

BIOSIMILAR

BioSim

BIOPROCESSING

BIOPHARMACEUTICAL

BIOLOGICAL DRUGS

BIOEQUIVALENCE

BIOAVAILABILITY

BIOACTIVITY

BINDING

BATCH CULTURE

BACULOVIRUS

BACTERIOPHAGE

A

AVIDITY

ANTIGENITCITY

ANTIGEN DETERMINANT

ANTIGEN

ANTIBODY

Active ingredient (or active substance)

  • Portfolio
  • Blog mAbxience
  • Contact Us
  • Privacy & Terms
  • Cookies Policy
  • Glossary

© 2022 mAbxience, creating a strong value in biopharmaceuticals